Items where authors include "Gilberts, R."

Article

Bojke, C. orcid.org/0000-0003-2601-0314, Konwea, H., Nelson, E.A. et al. (14 more authors) (2025) Cost‐effectiveness of swab versus tissue sampling for infected diabetic foot ulcers from the CODIFI2 randomised controlled trial. Diabetic Medicine. e15492. ISSN 0742-3071

Wittmann, M., Smith, I.L., Brown, S.T. et al. (11 more authors) (2024) Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT. Health Technology Assessment, 28 (59). pp. 1-123. ISSN 1366-5278

Gale, C.P., Stocken, D.D., Aktaa, S. et al. (11 more authors) (2024) Effectiveness of the GRACE risk score according to troponin elevation in patients admitted with non-ST elevation acute coronary syndrome: a post-hoc analysis of the UKGRIS cluster RCT. European Heart Journal, 45 (Supplement_1). ehae666.1690. ISSN 0195-668X

Cragg, W.J. orcid.org/0000-0002-1274-8521, Bishop, L. orcid.org/0000-0003-0890-2423, Gilberts, R. orcid.org/0000-0003-3326-7900 et al. (3 more authors) (2024) Views of research ethics committee members on end-of-participation communications for trial participants who stop taking part: a cross-sectional survey study. Trials, 25. 636. ISSN 1745-6215

Cragg, W.J. orcid.org/0000-0002-1274-8521, Taylor, C., Moreau, L. orcid.org/0000-0002-0280-6345 et al. (12 more authors) (2024) Approaches and experiences implementing remote, electronic consent at the Leeds Clinical Trials Research Unit. Trials, 25. 310. ISSN 1745-6215

Cragg, W.J. orcid.org/0000-0002-1274-8521, Bishop, L. orcid.org/0000-0003-0890-2423, Gilberts, R. orcid.org/0000-0003-3326-7900 et al. (5 more authors) (2024) How can we support research participants who stop taking part? Communications guidance developed through public-researcher collaboration. Research Involvement and Engagement, 10. 39. ISSN 2056-7529

Smith, I.L. orcid.org/0000-0002-8326-1075, Gilberts, R. orcid.org/0000-0003-3326-7900, Brown, S. orcid.org/0000-0002-1840-3786 et al. (14 more authors) (2022) Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial. BMJ Open, 12 (2). e060029. ISSN 2044-6055

Conference or Workshop Item

Bishop, L. orcid.org/0000-0003-0890-2423, Smith, I., Gilberts, R. et al. (2 more authors) (2023) Cp4-4 dermatology trial design considerations to improve diversity and inclusion of patients from ethnic minority backgrounds. In: Society for Clinical Trials 44th Annual Meeting (2023), 21-24 May 2023, Baltimore, MD.

Bishop, L. orcid.org/0000-0003-0890-2423, Smith, I., Gilberts, R. et al. (2 more authors) (2023) P31 Trial design to improve inclusion of patients from ethnic minority backgrounds. In: British Association of Dermatologists Annual Meeting 2023, 27-29 Jun 2023, Liverpool, UK.

Proceedings Paper

Wittmann, M., Smith, I., Brown, S. orcid.org/0000-0002-1840-3786 et al. (10 more authors) (2023) 006 Comparison of alitretinoin vs. psoralen plus ultraviolet A as first-line treatments for chronic severe hand eczema: results from the ALPHA trial. In: British Journal of Dermatology. British Association of Dermatologists 103rd Annual Meeting, 27-29 Jun 2023, Liverpool, UK. Oxford University Press , ljad113.006.